Related content

Chemotherapy Options for Patients with Relapsed Epithelial Ovarian Cancer

By Larkin J.M.G.   Gore M.E.  

American Journal of Cancer, Vol. 1, Iss. 3, 2002-03 ,pp. : 205-216

Adis International

Access to resources Recommend Favorite

Paclitaxel-Anthracycline Combination Chemotherapy in Relapsing Advanced Ovarian Cancer after Platinum-Based Chemotherapy: A Pilot Study

By Kurtz J.E.   Deplanque G.   Duclos B.   Eichler F.   Giron C.   Limacher J.M.   Herbrecht R.   Maloisel F.   Oberling F.   Bergerat J.P.   Dufour P.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 414-417

Elsevier

Access to resources Recommend Favorite

A Pilot Study of Predictive Markers of Chemotherapy-Related Amenorrhea Among Premenopausal Women with Early Stage Breast Cancer

By Anders Carey   Marcom P. Kelly   Peterson Bercedis   Gu Lin   Unruhe Sue   Welch Renee   Lyons Peggy   Kimmick Gretchen   Shaw Heather   Snyder Stacey   Antenos Monica   Woodruff Teresa   Blackwell Kimberly  

Cancer Investigation, Vol. 26, Iss. 3, 2008-03 ,pp. : 286-295

Informa Healthcare

Access to resources Recommend Favorite

Regional abdominal hyperthermia combined with systemic chemotherapy for the treatment of patients with ovarian cancer relapse: Results of a pilot study

By Fotopoulou Christina   Hee Cho Chie   Kraetschell Robert   Gellermann Johanna   Wust Peter   Lichtenegger Werner   Sehouli Jalid  

International Journal of Hyperthermia, Vol. 26, Iss. 2, 2010-05 ,pp. : 118-126

Informa Healthcare

Access to resources Recommend Favorite

A pilot study of combination intraperitoneal recombinant human endostatin and chemotherapy for refractory malignant ascites secondary to ovarian cancer

By Zhao Jing   Chen Xinxiao   Zhang Aimu   Xu Feng   Hu Meilong   Xie Congying   Xue Shengliu  

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-7

Humana Press, Inc

Access to resources Recommend Favorite